These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 4591267)

  • 1. Early splenectomy in lymphoproliferative disorders.
    Yam LT; Crosby WH
    Arch Intern Med; 1974 Feb; 133(2):270-4. PubMed ID: 4591267
    [No Abstract]   [Full Text] [Related]  

  • 2. Splenectomy in malignant lymphoma and leukemia.
    Mittelman A; Stutzman L; Grace JT
    Geriatrics; 1968 May; 23(5):142-9. PubMed ID: 4869007
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic leukemia associated with hematosarcoma (double hematosis)].
    Wiedermann B; Cihal K; Bayer A; Vymetal A; Dedicova Z; Blatmy J
    Nouv Rev Fr Hematol; 1968; 8(2):242-7. PubMed ID: 4232369
    [No Abstract]   [Full Text] [Related]  

  • 4. [Spleen irradiation and splenectomy for treatment of hypersplenism in chronic myeloid leukemia and chronic lymphatic leukemia (author's transl)].
    Stolzenbach G; Franke HD; Montz R; Schulze PJ
    Strahlentherapie; 1979 Feb; 155(2):82-6. PubMed ID: 284643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Leukemic transformation of non-hodgkinian hematosarcomas (lymphomas). Efficacity of immunotherapy].
    Mathé G; Pouillart P; Schwarzenberg L; Hayat M; Amiel JL; Schlumberger JR; De Vassal F
    Bull Cancer; 1974; 61(1):69-78. PubMed ID: 4617612
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent developments in the treatment of hemopoietic and lymphoid neoplasms.
    Flexner JM
    J Tenn Med Assoc; 1977 Jan; 70(1):13-6. PubMed ID: 319299
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pleural manifestations of malignant lymphoreticulopathies].
    Galy P; Brune J; Morel P; Gentilhomme O; Berthou-Dorsit JD; Abbas M
    Sem Hop; 1967 Oct; 43(42):2614-25. PubMed ID: 4294005
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of non-Hodgkin's lymphoma.
    Pitney WR; Robilliard JF
    Med J Aust; 1974 Jul; 2(3):99-102. PubMed ID: 4606781
    [No Abstract]   [Full Text] [Related]  

  • 9. [Association of intralymphatic radiotherapy and alkylating agents in the treatment of retroperitoneal hematosarcomas].
    Bonadonna G; Chiappa S; Di Pietro S; Marano O; Molinari R; Uslenghi C
    Nouv Rev Fr Hematol; 1967; 7(3):381-92. PubMed ID: 4229322
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current data on cellular physiopathology of the lymphoid organs].
    Micu D
    Stud Cercet Med Interna; 1969; 10(5):395-409. PubMed ID: 4984242
    [No Abstract]   [Full Text] [Related]  

  • 11. Splenectomy for hypersplenism in Hodgkin's disease.
    ROUSSELOT LM; RELLA AJ; ROTTINO A
    Am J Surg; 1962 Jun; 103():769-74. PubMed ID: 14494561
    [No Abstract]   [Full Text] [Related]  

  • 12. Splenectomy for hypersplenism in Hodgkin's disease. A reappraisal.
    ROUSSELOT LM; RELLA AJ; ROTTINO A
    Am J Surg; 1962 Jun; 103():769-74. PubMed ID: 14494560
    [No Abstract]   [Full Text] [Related]  

  • 13. Splenectomy for hypersplenism in malignant lymphoma.
    O'Brien PH; Hartz WH; Derlacki D; Graulich K
    Arch Surg; 1970 Aug; 101(2):348-52. PubMed ID: 4916017
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lymphoproliferative diseases studied with lymphatic scintiscanning with colloidal Au 198].
    Rembado R; Marenco G; Cavaliere P; Puppo N
    Minerva Med; 1971 Aug; 62(63):2957-61. PubMed ID: 4935993
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of milurit in hyperuricemia in patients with malignant hemopathies].
    Poddubnaia IV; Mansurov AN; Fominykh VG
    Klin Med (Mosk); 1975 Mar; 53(3):94-9. PubMed ID: 1090781
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuropathy associated with lymphoma.
    Walsh JC
    Proc Aust Assoc Neurol; 1971; 8():111-9. PubMed ID: 4341114
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of splenectomy in malignant lymphoma and leukemia.
    Meeker WR; dePerio JM; Grace JT; Stutzman L; Mittelman A
    Surg Clin North Am; 1967 Oct; 47(5):1163-71. PubMed ID: 4885839
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value and action of cytostatics in malignant lymphatic system diseases].
    FLEISCHHACKER H; STACHER A
    Wien Z Inn Med; 1962 May; 43():200-8. PubMed ID: 13893500
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the phenomena of splenic lymphocytic endophagocytosis during reticulo-lymphopathies].
    Castoldi GL; Scapoli GL; Spanedda R; Grusovin GD
    Arch Ital Patol Clin Tumori; 1969; 12(3):143-61. PubMed ID: 4910959
    [No Abstract]   [Full Text] [Related]  

  • 20. The spleen in lymphoproliferative disorders.
    Christensen BE; Jønsson V; Videbaek A
    Clin Haematol; 1983 Jun; 12(2):517-33. PubMed ID: 6352115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.